✦ LIBER ✦

9081 A phase II retrospective trial of Carboplatin (CBDCA) and Alimta in refractory non-small cell lung cancer (NSCLC) with genetic polymorphisms analysis

✍ Scribed by Ludovini, V.; Pistola, L.; Floriani, I.; Meacci, M.; Chiari, R.; Stocchi, L.; Tofanetti, F.R.; Mare, M.; Giuffrida, D.; Crinò, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of double platinum with c

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Carboplatin (CBDCA), ifosfamide (IFX) an

✍ Candamio, S.; Menéndez, M.D.; Irigoyen, A.; Barón, F.J.; Vázquez, F.; Cueva, J.F 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

A phase-II trial of carboplatin (CBDCA)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

P-522 A phase II trial of Alimta plus ca

✍ Zinner, Ralph G.; Obasaju, Coleman K.; Fossella, Frank V.; Pisters, Katherine M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A phase II trial of carboplatin (CBDCA)

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase I/II trial of carboplatin and na

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB